Your browser doesn't support javascript.
loading
Local Tumor Control and Clinical Symptoms After Gamma Knife Radiosurgery for Residual and Recurrent Vestibular Schwannomas.
Suero Molina, Eric; van Eck, Albertus T C J; Sauerland, Cristina; Schipmann, Stephanie; Horstmann, Gerhard; Stummer, Walter; Brokinkel, Benjamin.
Affiliation
  • Suero Molina E; Department of Neurosurgery, University Hospital Münster, Münster, Germany.
  • van Eck ATCJ; Gamma Knife Center Krefeld, Krefeld, Germany.
  • Sauerland C; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Schipmann S; Department of Neurosurgery, University Hospital Münster, Münster, Germany.
  • Horstmann G; Gamma Knife Center Krefeld, Krefeld, Germany.
  • Stummer W; Department of Neurosurgery, University Hospital Münster, Münster, Germany.
  • Brokinkel B; Department of Neurosurgery, University Hospital Münster, Münster, Germany. Electronic address: benjamin.brokinkel@ukmuenster.de.
World Neurosurg ; 122: e1240-e1246, 2019 Feb.
Article in En | MEDLINE | ID: mdl-30447443
ABSTRACT

BACKGROUND:

The use of Gamma Knife radiosurgery (GKRS) for recurrent or residual vestibular schwannoma (VS) after microsurgery (MS) has been investigated in several retrospective studies. The purpose of this study was to identify potential risk factors for both neurologic deterioration and tumor progression after GKRS for previously operated VSs in a prospective setting.

METHODS:

Patients who underwent GKRS for previously operated and histopathologically confirmed VS between 1998 and 2015 were prospectively followed-up. Risk factors for therapy side effects and predictors for tumor control were investigated in uni- and multivariate analyses.

RESULTS:

A total of 160 individuals with a median age of 55 years were included. Median tumor volume prior to GKRS was 1.40 cm3 (range, 0.06-35.80 cm3). After a median follow-up of 36 months, hearing and facial nerve function were serviceable (modified Gardner-Robertson and House-Brackmann grades I and II) in 7 (5%) and 82 (55%) patients, respectively. Deterioration to a nonserviceable facial nerve function after GKRS was found in 3% (3/89) and tended to increase with rising tumor volume (odds ratio, 1.65 per cm3; 95% confidence interval, 1.00-2.71; P = 0.051). Median tumor volume prior to GKRS was higher in patients with radiologic (P = 0.020) or clinical tumor progression (P < 0.001). Critical tumor volume prior to GKRS to predict clinical and radiologic tumor progression was 1.30 cm3 (P < 0.001) and 3.30 cm3 (P = 0.019), respectively. However, in multivariate analyses, none of the analyzed variables were found to independently predict tumor progression.

CONCLUSIONS:

Intended submaximal resection followed by GKRS is a viable treatment for VS. Because tumor remnant size after MS is an important predictor for recurrence after adjuvant GKRS, both brainstem and cerebellar decompression and maximal safely achievable resection should remain major goals of microsurgery.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroma, Acoustic / Radiosurgery / Facial Nerve / Neoplasm Recurrence, Local Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: World Neurosurg Journal subject: NEUROCIRURGIA Year: 2019 Document type: Article Affiliation country: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroma, Acoustic / Radiosurgery / Facial Nerve / Neoplasm Recurrence, Local Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: World Neurosurg Journal subject: NEUROCIRURGIA Year: 2019 Document type: Article Affiliation country: Alemania